Investor Presentation

MONETIZING OUR POSITION IN HEMP/CANNABIS PLANT MODIFICATION BY ACCELERATING 22nd Century has demonstrated its ability to monetize proprietary hemp/cannabis plant lines necessary to achieve its full commercial potential. 22nd Century Group optimizes hemp/cannabis plant genetics and creates disruptive, proprietary stable commercial plant lines that deliver higher crop yield. ▪ Plant lines with optimized genetics for commercial farming methodologies Option to grow at scale indoors and outdoors Improved disease and pest resistance ▪ Ability to control the expression of CBD, THC, CBG, CBN, terpenes, and other cannabinoids is critical to financial returns and quality metrics ■ 22ND CENTURY GROUP ■ 13

View entire presentation